ONCY Key Stats
- MEDIA ADVISORY - Oncolytics Biotech® Inc. to Participate in the 34th Annual Cowen and Company Healthcare Conference CNW Group 03/04 16:00 ET
- 9:28 am Oncolytics Biotech announces initial $1 mln investment and up to $25 mln common share purchase agreement with Lincoln Park Capital Fund Yahoo 02/27 09:58 ET
- Oncolytics Biotech® Inc. Announces Initial US$1.0 Million Investment and Up to US$25.0 Million Common Share Purchase Agreement with Lincoln Park Capital Fund, LLC PR Newswire 02/27 09:26 ET
- 3 Biotech Stocks Under $10 to Trade for Breakouts Yahoo 02/26 06:00 ET
- Media Advisory - Oncolytics Biotech® Inc. to Participate in 2014 RBC Capital Markets Global Healthcare Conference PR Newswire 02/25 06:30 ET
- Oncolytics Biotech (ONCY) Soars: Stock Up 6.3% - Tale of the Tape Zacks 01/24 02:51 ET
- 5 Stocks Under $10 Set to Soar The Street 01/23 09:24 ET
- On the Road to Riches in Biotech Barrons.com 12/28 00:01 ET
- Oncolytics Biotech® Inc. to Present at the 25th Annual Piper Jaffray Healthcare Conference noodls 12/03 07:22 ET
- Oncolytics (ONCY) CEO Thompson to Present at Piper Jaffray Conference Street Insider 12/03 06:50 ET
ONCY Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Oncolytics Biotech is down 45.02% over the last year vs S&P 500 Total Return up 24.21%, Jazz Pharmaceuticals up 161.1%, and Actelion up 102.5%.
Balance Sheet View Statement
Pro Ratings for ONCY
Pro Strategies Featuring ONCY
Did Oncolytics Biotech make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: Canada
- Headquarters State/Province: Alberta
- Incorporation Country: Canada
- Incorporation State/Province: N/A
Oncolytics Biotech, Inc., is a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers.